Identification of leukemia stem cells in acute myeloid leukemia and their clinical relevance.

@article{Hong2012IdentificationOL,
  title={Identification of leukemia stem cells in acute myeloid leukemia and their clinical relevance.},
  author={Văn Th{\`a}nh Ho{\`a}ng and Abraham Zepeda-Moreno and Anthony D. Ho},
  journal={Biotechnology journal},
  year={2012},
  volume={7 6},
  pages={
          779-88
        }
}

• Văn Thành Hoàng, Abraham Zepeda-Moreno, Anthony D. Ho
• Published in Biotechnology journal 2012
• DOI:10.1002/biot.201100350

Acute myeloid leukemia (AML) is considered to be a disease of stem cells. A rare defective stem cell population is purported to drive tumor growth. Similarly to their normal counterparts, leukemic stem cells (LSC) divide extreme slowly. This may explain the ineffectiveness of conventional chemotherapy in combatting this disease. Novel treatment strategies aimed at disrupting the binding of LSC to stem cell niches within the bone marrow might render the LSC vulnerable to chemotherapy and thus… CONTINUE READING

View on Wiley

BETA

Alternate Sources

Save to Library

Create Alert

Cite